<?xml version="1.0" encoding="ISO-8859-1"?>
<BiblioData DataBase="ESPACENET" Version="221" Datum="2012-07-14">
<SubDatabase>
espacenet
</SubDatabase>
<Title>
SOLID SUBSTRATE WITH SURFACE BOUND MOLECULES AND METHODS FOR PRODUCING AND USING THE SAME
</Title>
<PublicationNumber>
EP2191267A2
</PublicationNumber>
<Inventor>
<Name>
PARK JOON WON [KR]
</Name>
<Name>
HONG BONG JIN [KR]
</Name>
<Name>
KIM DUK HOE [KR]
</Name>
<Name>
PARK, JOON WON
</Name>
<Name>
HONG, BONG JIN
</Name>
<Name>
KIM, DUK HOE
</Name>
</Inventor>
<Applicant>
<Name>
POSTECH ACAD IND FOUND [KR]
</Name>
<Name>
POSCO [KR]
</Name>
<Name>
POSTECH ACADEMY-INDUSTRY FOUNDATION
</Name>
<Name>
POSCO
</Name>
</Applicant>
<RequestedPatent>
EP2191267
</RequestedPatent>
<ApplicationElem>
<Number>
EP20080831597
</Number>
</ApplicationElem>
<ApplicationDate>
2008-09-17
</ApplicationDate>
<PriorityElem>
<PriorityNumber>
WO2008IB03808
</PriorityNumber>
<PriorityDate>
2008-09-17
</PriorityDate>
<PriorityNumber>
US20070973079P
</PriorityNumber>
<PriorityDate>
2007-09-17
</PriorityDate>
</PriorityElem>
<IPC>
<Class>
C12Q1/68
</Class>
<Class>
G01N33/48
</Class>
</IPC>
<NCL>
<Class>
B82Y35/00
</Class>
<Class>
B82Y5/00
</Class>
<Class>
G01N33/543B
</Class>
<Class>
G01N33/543K2
</Class>
<Class>
G01N33/543M
</Class>
<Class>
G01Q60/42
</Class>
</NCL>
<Abstract>
The present invention provides solid substrates comprising a small number of molecules, for example, ten or less molecules on the convex surface, e.g., on the apex, and methods for producing and using the same.
</Abstract>
<Claims>
<P>
What is Claimed:
</P>
<P>
1. A method for modifying a solid substrate surface comprising: attaching a receptor to a convex surface of a first solid substrate surface to produce a receptor-bound substrate comprising a plurality of receptors; contacting the receptor-bound substrate with a ligand that is bound to the surface of a second solid substrate under conditions sufficient to produce a receptor-ligand complex bound solid substrate wherein only a portion of the plurality of receptors is complexed to the ligand; and modifying the receptor-ligand complex to produce a surface modified solid substrate.
</P>
<P>
2. The method of Claim 1, wherein about 3 or less of the receptors are complexed to the ligand.
</P>
<P>
3. The method of Claim 2, wherein only a single receptor is complexed to the ligand.
</P>
<P>
4. The method of Claim 1, wherein the receptor-ligand complex is a double stranded oligonucleotide, antigen-antibody complex, oligopeptide-small molecule complex, or oligopeptide-oligopeptide complex.
</P>
<P>
5. The method of Claim 4, wherein the receptor-ligand complex is a double stranded oligonucleotide.
</P>
<P>
6. The method of Claim 5, wherein said step of modifying the receptor-ligand complex further comprises: contacting the double stranded oligonulceotide with a metal ion under conditions sufficient to form a double stranded oligonucleotide-metal ion complex; and reducing the metal ion under conditions sufficient to produce the surface modified solid substrate comprising a surface bound metal nanorod.
</P>
<P>
7. The method of Claim 5, wherein said step of modifying the receptor-ligand complex further comprises contacting the double stranded oligonulceotide with an intercalator- metal catalyst complex under conditions sufficient to produce the surface modified solid substrate comprising a surface bound double stranded oligonucleotide with the intercalator-metal catalyst intercalated therein. 8. The method of Claim 5, wherein said step of modifying the receptor- ligand complex comprises: denaturing the double stranded oligonucleotide to produce a single strand oligonucleotide-bound substrate; and hybridizing the single strand oligonucleotide with
</P>
<P>
(i) a labeled complementary oligonucleotide under conditions sufficient to produce the surface modified solid substrate comprising a surface bound labeled double-stranded oligonucleotide; or (ii) a complementary oligonucleotide comprising an enzyme or a catalyst under conditions sufficient to produce the surface modified solid substrate comprising the enzyme or the catalyst that is attached to a surface bound double-stranded oligonucleotide.
</P>
<P>
9. The method of Claim 8 further comprising the step of cleaving from the solid substrate surface at least a portion of the unbound single stranded oligonucleotides prior to said step of denaturing the double stranded oligonucleotide.
</P>
<P>
10. The method of Claim 5, wherein said step of contacting the receptor-bound substrate with a ligand that is bound to the surface of a second solid substrate comprises: contacting the first solid substrate surface bound ssDNA with a linker ssDNA that is hybridized to a ssDNA that is attached to the second solid substrate surface under conditions sufficient to produce the receptor-ligand complex bound solid substrate, wherein the linker ssDNA comprises: (i) a first DNA portion that is capable of hybridizing to the ssDNA that is attached to the surface of the first solid substrate; (ii) a second DNA portion that is capable of hybridizing to the ssDNA that is attached to the surface of the second solid substrate surface; and (iii) optionally a probe.
</P>
<P>
11. The method of Claim 10, wherein the linker ssDNA comprises a probe.
</P>
<P>
12. The method of Claim 4, wherein the receptor-ligand complex is a antigen- antibody complex. 13. The method of Claim 12, wherein said step of modifying the receptor- ligand complex comprises contacting the antigen-antibody complex with a second antibody under conditions sufficient to produce the surface modified solid substrate comprising a surface bound complex of antigen-antibody-second antibody.
</P>
<P>
14. The method of Claim 13, wherein said step of modifying the receptor- ligand complex further comprises adding an enzyme-linked secondary antibody under conditions sufficient to produce the surface modified solid substrate comprising a surface bound complex of antibody-antigen-enzyme linked secondary antibody.
</P>
<P>
15. The method of Claim 13, wherein said step of modifying the receptor- ligand complex further comprises adding a metal-linked secondary antibody under conditions sufficient to produce the surface modified substrate comprising a surface bound complex of antibody- antigen-metal linked secondary antibody.
</P>
<P>
16. The method of Claim 1, wherein the receptor is attached to the first solid substrate via a surface-bound linker.
</P>
<P>
17. The method of Claim 16, wherein the surface-bound linker comprises: a central atom; a functional group that is attached to the central atom through a linker and is attached to a receptor; and a base portion attached to said central atom and having a plurality of termini that are attached to said first surface of said solid support.
</P>
<P>
18. The method of Claim 17, wherein the surface-bound linker is of the formula:
</P>
<P>
I wherein each of m, a, b, and c is independently 0 or 1; x is 1 when c is 0 or when c is 1, x is an integer from 1 to the oxidation state of Q&amp;lt;4&amp;gt;-l; y is 1 when b is 0 or when b is 1, y is an integer from 1 to the oxidation state of Q&amp;lt;3&amp;gt;-l; z is 1 when a is 0 or when a is 1, z is an integer from 1 to the oxidation state of Q&amp;lt;2&amp;gt;-l; n is an integer from 1 to the oxidation state of Q&amp;lt;1&amp;gt;-!; Q&amp;lt;1&amp;gt; is a central atom having the oxidation state of at least 3; each of Q&amp;lt;2&amp;gt;, Q&amp;lt;3&amp;gt; and Q&amp;lt;4&amp;gt; is independently a branch atom having the oxidation state of at least 3; each of R&amp;lt;1&amp;gt;, R&amp;lt;2&amp;gt;, R&amp;lt;3&amp;gt;, R&amp;lt;4&amp;gt;, and R&amp;lt;5&amp;gt; is independently a linker; Z is the functional group that is attached to a receptor; and each of Y is independently a functional group on the terminus of said base portion, wherein a plurality of Y are attached to said first surface of said solid support, provided the product of n, x, y, and z is at least 3.
</P>
<P>
19. The method of Claim 18, wherein Z comprises a heteroatom selected from the group consisting of N, O, S, P, and a combination thereof.
</P>
<P>
20. The method of Claim 1, wherein the first solid substrate is an atomic force microscope tip.
</P>
<P>
21. A solid substrate adapted for performing an analytical analysis comprising a convex surface, wherein said convex surface comprises a plurality of surface bound dendrons comprising a receptor adapted for forming a complex with a ligand such that when said plurality of receptors is contacted with a ligand that is bound to the surface of a second solid substrate only a portion of plurality of receptors becomes complexed to the ligand.
</P>
<P>
22. The solid substrate of Claim 21, wherein said solid substrate is an atomic force microscope tip.
</P>
<P>
23. The solid substrate of Claim 21, wherein said dendron is of the formula:
</P>
<P>
Z-CR^-Q -ICR&apos;-Q^a-KR&apos;-Q^b-CCR&apos;-Q^c-CR&apos;-Y^Jylzln
</P>
<P>
I wherein each of m, a, b, and c is independently 0 or 1; x is 1 when c is 0 or when c is 1, x is an integer from 1 to the oxidation state of Q&amp;lt;4&amp;gt;-l; y is 1 when b is 0 or when b is 1, y is an integer from 1 to the oxidation state of Q -1; z is 1 when a is 0 or when a is 1, z is an integer from 1 to the oxidation state of Q&amp;lt;2&amp;gt;-l; n is an integer from 1 to the oxidation state of Q&amp;lt;!&amp;gt;-l;
</P>
<P>
Q&amp;lt;1&amp;gt; is a central atom having the oxidation state of at least 3; each of Q&amp;lt;2&amp;gt;, Q&amp;lt;3&amp;gt; and Q&amp;lt;4&amp;gt; is independently a branch atom having the oxidation state of at least 3; each of R&amp;lt;1&amp;gt;, R&amp;lt;2&amp;gt;, R&amp;lt;3&amp;gt;, R&amp;lt;4&amp;gt;, and R&amp;lt;5&amp;gt; is independently a linker; Z is functional group linked to said receptor; and each of Y is independently a functional group on the terminus of said base portion, wherein a plurality of Y are attached to said first surface of said solid support, provided the product of n, x, y, and z is at least 3.
</P>
<P>
24. The solid substrate of Claim 21 , wherein said receptor is an oligonucleotide, an oligopeptide, an antibody, an antigen, a receptor, an enzyme, aptamer, or other biologically or pharmaceutically active compounds.
</P>
<P>
25. An article suitable for use in an Atomic Force Microscope comprising a convex surface and 3 or less probe molecules attached to the apex of said convex surface.
</P>
<P>
26. The article of Claim 25, wherein said convex surface comprises a single probe molecule.
</P>
<P>
What is Claimed:
</P>
<P>
1. A method for modifying a solid substrate surface comprising: attaching a receptor to a convex surface of a first solid substrate surface to produce a receptor-bound substrate comprising a plurality of receptors; contacting the receptor-bound substrate with a ligand that is bound to the surface of a second solid substrate under conditions sufficient to produce a receptor-ligand complex bound solid substrate wherein only a portion of the plurality of receptors is complexed to the ligand; and modifying the receptor-ligand complex to produce a surface modified solid substrate.
</P>
<P>
2. The method of Claim 1, wherein about 3 or less of the receptors are complexed to the ligand.
</P>
<P>
3. The method of Claim 2, wherein only a single receptor is complexed to the ligand.
</P>
<P>
4. The method of Claim 1, wherein the receptor-ligand complex is a double stranded oligonucleotide, antigen-antibody complex, oligopeptide-small molecule complex, or oligopeptide-oligopeptide complex.
</P>
<P>
5. The method of Claim 4, wherein the receptor-ligand complex is a double stranded oligonucleotide.
</P>
<P>
6. The method of Claim 5, wherein said step of modifying the receptor-ligand complex further comprises: contacting the double stranded oligonulceotide with a metal ion under conditions sufficient to form a double stranded oligonucleotide-metal ion complex; and reducing the metal ion under conditions sufficient to produce the surface modified solid substrate comprising a surface bound metal nanorod.
</P>
<P>
7. The method of Claim 5, wherein said step of modifying the receptor-ligand complex further comprises contacting the double stranded oligonulceotide with an intercalator- metal catalyst complex under conditions sufficient to produce the surface modified solid substrate comprising a surface bound double stranded oligonucleotide with the intercalator-metal catalyst intercalated therein. 8. The method of Claim 5, wherein said step of modifying the receptor- ligand complex comprises: denaturing the double stranded oligonucleotide to produce a single strand oligonucleotide-bound substrate; and hybridizing the single strand oligonucleotide with
</P>
<P>
(i) a labeled complementary oligonucleotide under conditions sufficient to produce the surface modified solid substrate comprising a surface bound labeled double-stranded oligonucleotide; or (ii) a complementary oligonucleotide comprising an enzyme or a catalyst under conditions sufficient to produce the surface modified solid substrate comprising the enzyme or the catalyst that is attached to a surface bound double-stranded oligonucleotide.
</P>
<P>
9. The method of Claim 8 further comprising the step of cleaving from the solid substrate surface at least a portion of the unbound single stranded oligonucleotides prior to said step of denaturing the double stranded oligonucleotide.
</P>
<P>
10. The method of Claim 5, wherein said step of contacting the receptor-bound substrate with a ligand that is bound to the surface of a second solid substrate comprises: contacting the first solid substrate surface bound ssDNA with a linker ssDNA that is hybridized to a ssDNA that is attached to the second solid substrate surface under conditions sufficient to produce the receptor-ligand complex bound solid substrate, wherein the linker ssDNA comprises: (i) a first DNA portion that is capable of hybridizing to the ssDNA that is attached to the surface of the first solid substrate; (ii) a second DNA portion that is capable of hybridizing to the ssDNA that is attached to the surface of the second solid substrate surface; and (iii) optionally a probe.
</P>
<P>
11. The method of Claim 10, wherein the linker ssDNA comprises a probe.
</P>
<P>
12. The method of Claim 4, wherein the receptor-ligand complex is a antigen- antibody complex. 13. The method of Claim 12, wherein said step of modifying the receptor- ligand complex comprises contacting the antigen-antibody complex with a second antibody under conditions sufficient to produce the surface modified solid substrate comprising a surface bound complex of antigen-antibody-second antibody.
</P>
<P>
14. The method of Claim 13, wherein said step of modifying the receptor- ligand complex further comprises adding an enzyme-linked secondary antibody under conditions sufficient to produce the surface modified solid substrate comprising a surface bound complex of antibody-antigen-enzyme linked secondary antibody.
</P>
<P>
15. The method of Claim 13, wherein said step of modifying the receptor- ligand complex further comprises adding a metal-linked secondary antibody under conditions sufficient to produce the surface modified substrate comprising a surface bound complex of antibody- antigen-metal linked secondary antibody.
</P>
<P>
16. The method of Claim 1, wherein the receptor is attached to the first solid substrate via a surface-bound linker.
</P>
<P>
17. The method of Claim 16, wherein the surface-bound linker comprises: a central atom; a functional group that is attached to the central atom through a linker and is attached to a receptor; and a base portion attached to said central atom and having a plurality of termini that are attached to said first surface of said solid support.
</P>
<P>
18. The method of Claim 17, wherein the surface-bound linker is of the formula:
</P>
<P>
I wherein each of m, a, b, and c is independently 0 or 1; x is 1 when c is 0 or when c is 1, x is an integer from 1 to the oxidation state of Q&amp;lt;4&amp;gt;-l; y is 1 when b is 0 or when b is 1, y is an integer from 1 to the oxidation state of Q&amp;lt;3&amp;gt;-l; z is 1 when a is 0 or when a is 1, z is an integer from 1 to the oxidation state of Q&amp;lt;2&amp;gt;-l; n is an integer from 1 to the oxidation state of Q&amp;lt;1&amp;gt;-!; Q&amp;lt;1&amp;gt; is a central atom having the oxidation state of at least 3; each of Q&amp;lt;2&amp;gt;, Q&amp;lt;3&amp;gt; and Q&amp;lt;4&amp;gt; is independently a branch atom having the oxidation state of at least 3; each of R&amp;lt;1&amp;gt;, R&amp;lt;2&amp;gt;, R&amp;lt;3&amp;gt;, R&amp;lt;4&amp;gt;, and R&amp;lt;5&amp;gt; is independently a linker; Z is the functional group that is attached to a receptor; and each of Y is independently a functional group on the terminus of said base portion, wherein a plurality of Y are attached to said first surface of said solid support, provided the product of n, x, y, and z is at least 3.
</P>
<P>
19. The method of Claim 18, wherein Z comprises a heteroatom selected from the group consisting of N, O, S, P, and a combination thereof.
</P>
<P>
20. The method of Claim 1, wherein the first solid substrate is an atomic force microscope tip.
</P>
<P>
21. A solid substrate adapted for performing an analytical analysis comprising a convex surface, wherein said convex surface comprises a plurality of surface bound dendrons comprising a receptor adapted for forming a complex with a ligand such that when said plurality of receptors is contacted with a ligand that is bound to the surface of a second solid substrate only a portion of plurality of receptors becomes complexed to the ligand.
</P>
<P>
22. The solid substrate of Claim 21, wherein said solid substrate is an atomic force microscope tip.
</P>
<P>
23. The solid substrate of Claim 21, wherein said dendron is of the formula:
</P>
<P>
Z-CR^-Q -ICR&apos;-Q^a-KR&apos;-Q^b-CCR&apos;-Q^c-CR&apos;-Y^Jylzln
</P>
<P>
I wherein each of m, a, b, and c is independently 0 or 1; x is 1 when c is 0 or when c is 1, x is an integer from 1 to the oxidation state of Q&amp;lt;4&amp;gt;-l; y is 1 when b is 0 or when b is 1, y is an integer from 1 to the oxidation state of Q -1; z is 1 when a is 0 or when a is 1, z is an integer from 1 to the oxidation state of Q&amp;lt;2&amp;gt;-l; n is an integer from 1 to the oxidation state of Q&amp;lt;!&amp;gt;-l;
</P>
<P>
Q&amp;lt;1&amp;gt; is a central atom having the oxidation state of at least 3; each of Q&amp;lt;2&amp;gt;, Q&amp;lt;3&amp;gt; and Q&amp;lt;4&amp;gt; is independently a branch atom having the oxidation state of at least 3; each of R&amp;lt;1&amp;gt;, R&amp;lt;2&amp;gt;, R&amp;lt;3&amp;gt;, R&amp;lt;4&amp;gt;, and R&amp;lt;5&amp;gt; is independently a linker; Z is functional group linked to said receptor; and each of Y is independently a functional group on the terminus of said base portion, wherein a plurality of Y are attached to said first surface of said solid support, provided the product of n, x, y, and z is at least 3.
</P>
<P>
24. The solid substrate of Claim 21 , wherein said receptor is an oligonucleotide, an oligopeptide, an antibody, an antigen, a receptor, an enzyme, aptamer, or other biologically or pharmaceutically active compounds.
</P>
<P>
25. An article suitable for use in an Atomic Force Microscope comprising a convex surface and 3 or less probe molecules attached to the apex of said convex surface.
</P>
<P>
26. The article of Claim 25, wherein said convex surface comprises a single probe molecule.
</P>
</Claims>
<Also_published_as>
EP2191267A4;WO2009037600A2;WO2009037600A3;US2011160088A1;JP2010539468A;CN101821617A
</Also_published_as>
</BiblioData>
